MTAP NEGATIVE

Clinical trials for MTAP NEGATIVE explained in plain language.

Never miss a new study

Get alerted when new MTAP NEGATIVE trials appear

Sign up with your email to follow new studies for MTAP NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo shows promise for Hard-to-Treat bladder cancer

Disease control Ongoing

This study tested a combination of two drugs, pemetrexed and avelumab, in 18 people with a rare, advanced form of bladder cancer that lacks a protein called MTAP. The goal was to see if the drugs could shrink or control the cancer. Pemetrexed blocks enzymes that cancer cells need…

Matched conditions: MTAP NEGATIVE

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 01, 2026 15:59 UTC

MTAP NEGATIVE

Get alerted when new MTAP NEGATIVE trials appear

New drug combo shows promise for Hard-to-Treat bladder cancer